Chardan Capital Initiates Ophthotech At Buy

Analysts at Chardan Capital initiated coverage on Ophthotech Corporation (NASDAQ: OPHT) with a Buy rating.

The target price for Ophthotech is set to $80.

Ophthotech shares have gained 47.77% over the past 52 weeks, while the S&P 500 index has surged 14.85% in the same period.

Ophthotech shares rose 1.29% to $54.00 in pre-market trading.